Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-007638
Filing Date
2010-02-08
Accepted
2010-02-08 18:53:24
Documents
1
Period of Report
2010-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6694
  Complete submission text file 0001209191-10-007638.txt   9617
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON STREET SUITE 1500 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1500 BOSTON MA 02199 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 10582074

Mailing Address 800 BOYLSTON STREET, SUITE 1500 BOSTON MA 02199
Business Address 800 BOYLSTON STREET, SUITE 1500 BOSTON MA 02199 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 10582076

Mailing Address 800 BOYLSTON STREET, SUITE 1500 BOSTON MA 02199
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 10582075